| Year |
Citation |
Score |
| 2024 |
Fredman G, Serhan CN. Specialized pro-resolving mediators in vascular inflammation and atherosclerotic cardiovascular disease. Nature Reviews. Cardiology. PMID 38216693 DOI: 10.1038/s41569-023-00984-x |
0.338 |
|
| 2023 |
Fredman G, Khan S. Specialized pro-resolving mediators enhance the clearance of dead cells. Immunological Reviews. 319: 151-157. PMID 37787174 DOI: 10.1111/imr.13278 |
0.346 |
|
| 2023 |
Spite M, Fredman G. Insights into the role of the resolvin D2-GPR18 signaling axis in cardiovascular physiology and disease. Advances in Pharmacology (San Diego, Calif.). 97: 257-281. PMID 37236761 DOI: 10.1016/bs.apha.2022.12.005 |
0.304 |
|
| 2023 |
Grazda R, Seyfried AN, Maddipatti KR, Fredman G, MacNamara KC. Impaired inflammation resolution in murine bone marrow failure is rescued by Resolvin E1 treatment. Biorxiv : the Preprint Server For Biology. PMID 36909559 DOI: 10.1101/2023.02.15.528688 |
0.366 |
|
| 2022 |
Fredman G, MacNamara KC. Atherosclerosis is a major human killer and non-resolving inflammation is a prime suspect. Cardiovascular Research. 117: 2563-2574. PMID 34609505 DOI: 10.1093/cvr/cvab309 |
0.346 |
|
| 2021 |
Decker C, Sadhu S, Fredman G. Pro-Resolving Ligands Orchestrate Phagocytosis. Frontiers in Immunology. 12: 660865. PMID 34177900 DOI: 10.3389/fimmu.2021.660865 |
0.324 |
|
| 2019 |
Gerlach BD, Marinello M, Heinz J, Rymut N, Sansbury BE, Riley CO, Sadhu S, Hosseini Z, Kojima Y, Tang DD, Leeper NJ, Spite M, Barroso M, Rayner KJ, Fredman G. Resolvin D1 promotes the targeting and clearance of necroptotic cells. Cell Death and Differentiation. PMID 31222041 DOI: 10.1038/S41418-019-0370-1 |
0.31 |
|
| 2019 |
Fredman G. Can Inflammation-Resolution Provide Clues to Treat Patients According to Their Plaque Phenotype? Frontiers in Pharmacology. 10: 205. PMID 30899222 DOI: 10.3389/fphar.2019.00205 |
0.317 |
|
| 2017 |
Yurdagul A, Doran AC, Cai B, Fredman G, Tabas IA. Mechanisms and Consequences of Defective Efferocytosis in Atherosclerosis. Frontiers in Cardiovascular Medicine. 4: 86. PMID 29379788 DOI: 10.3389/Fcvm.2017.00086 |
0.336 |
|
| 2017 |
Fredman G, Tabas I. Boosting Inflammation Resolution in Atherosclerosis: The Next Frontier for Therapy. The American Journal of Pathology. 187: 1211-1221. PMID 28527709 DOI: 10.1016/J.Ajpath.2017.01.018 |
0.315 |
|
| 2017 |
Heinz J, Marinello M, Fredman G. Pro-resolution therapeutics for cardiovascular diseases. Prostaglandins & Other Lipid Mediators. 132: 12-16. PMID 28450270 DOI: 10.1016/j.prostaglandins.2017.03.004 |
0.328 |
|
| 2017 |
Fredman G, Spite M. Specialized pro-resolving mediators in cardiovascular diseases. Molecular Aspects of Medicine. 58: 65-71. PMID 28257820 DOI: 10.1016/J.Mam.2017.02.003 |
0.377 |
|
| 2017 |
Cai B, Thorp EB, Doran AC, Sansbury BE, Daemen MJ, Dorweiler B, Spite M, Fredman G, Tabas I. MerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis. The Journal of Clinical Investigation. PMID 28067670 DOI: 10.1172/Jci90520 |
0.306 |
|
| 2016 |
Fredman G, Sadhu S, Rymut N. Fine-tuning inflammation-resolution programs: focus on atherosclerosis. Current Opinion in Clinical Nutrition and Metabolic Care. PMID 27984234 DOI: 10.1097/MCO.0000000000000351 |
0.345 |
|
| 2016 |
Fredman G, Hellmann J, Proto JD, Kuriakose G, Colas RA, Dorweiler B, Connolly ES, Solomon R, Jones DM, Heyer EJ, Spite M, Tabas I. An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques. Nature Communications. 7: 12859. PMID 27659679 DOI: 10.1038/Ncomms12859 |
0.398 |
|
| 2016 |
Cai B, Thorp EB, Doran AC, Subramanian M, Sansbury BE, Lin CS, Spite M, Fredman G, Tabas I. MerTK cleavage limits proresolving mediator biosynthesis and exacerbates tissue inflammation. Proceedings of the National Academy of Sciences of the United States of America. PMID 27199481 DOI: 10.1073/Pnas.1524292113 |
0.371 |
|
| 2016 |
Kamaly N, Fredman G, Fojas JJ, Subramanian M, Choi WI, Zepeda K, Vilos C, Yu M, Gadde S, Wu J, Milton J, Carvalho Leitao R, Rosa Fernandes L, Hasan M, Gao H, et al. Targeted Interleukin-10 Nanotherapeutics Developed with a Microfluidic Chip Enhance Resolution of Inflammation in Advanced Atherosclerosis. Acs Nano. PMID 27100066 DOI: 10.1021/Acsnano.6B01114 |
0.339 |
|
| 2015 |
Fredman G, Kamaly N, Spolitu S, Milton J, Ghorpade D, Chiasson R, Kuriakose G, Perretti M, Farokhzad O, Farokzhad O, Tabas I. Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice. Science Translational Medicine. 7: 275ra20. PMID 25695999 DOI: 10.1126/Scitranslmed.Aaa1065 |
0.364 |
|
| 2015 |
Leoni G, Neumann PA, Kamaly N, Quiros M, Nishio H, Jones HR, Sumagin R, Hilgarth RS, Alam A, Fredman G, Argyris I, Rijcken E, Kusters D, Reutelingsperger C, Perretti M, et al. Annexin A1-containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair. The Journal of Clinical Investigation. 125: 1215-27. PMID 25664854 DOI: 10.1172/Jci76693 |
0.352 |
|
| 2014 |
Fredman G, Ozcan L, Spolitu S, Hellmann J, Spite M, Backs J, Tabas I. Resolvin D1 limits 5-lipoxygenase nuclear localization and leukotriene B4 synthesis by inhibiting a calcium-activated kinase pathway. Proceedings of the National Academy of Sciences of the United States of America. 111: 14530-5. PMID 25246560 DOI: 10.1073/Pnas.1410851111 |
0.392 |
|
| 2014 |
Libby P, Tabas I, Fredman G, Fisher EA. Inflammation and its resolution as determinants of acute coronary syndromes. Circulation Research. 114: 1867-79. PMID 24902971 DOI: 10.1161/Circresaha.114.302699 |
0.325 |
|
| 2013 |
Kamaly N, Fredman G, Subramanian M, Gadde S, Pesic A, Cheung L, Fayad ZA, Langer R, Tabas I, Farokhzad OC. Development and in vivo efficacy of targeted polymeric inflammation-resolving nanoparticles. Proceedings of the National Academy of Sciences of the United States of America. 110: 6506-11. PMID 23533277 DOI: 10.1073/Pnas.1303377110 |
0.367 |
|
| 2013 |
Gao L, Faibish D, Fredman G, Herrera BS, Chiang N, Serhan CN, Van Dyke TE, Gyurko R. Resolvin E1 and chemokine-like receptor 1 mediate bone preservation. Journal of Immunology (Baltimore, Md. : 1950). 190: 689-94. PMID 23241890 DOI: 10.4049/Jimmunol.1103688 |
0.455 |
|
| 2012 |
Chiang N, Fredman G, Bäckhed F, Oh SF, Vickery T, Schmidt BA, Serhan CN. Infection regulates pro-resolving mediators that lower antibiotic requirements. Nature. 484: 524-8. PMID 22538616 DOI: 10.1038/Nature11042 |
0.37 |
|
| 2012 |
Oh SF, Dona M, Fredman G, Krishnamoorthy S, Irimia D, Serhan CN. Resolvin E2 formation and impact in inflammation resolution. Journal of Immunology (Baltimore, Md. : 1950). 188: 4527-34. PMID 22450811 DOI: 10.4049/Jimmunol.1103652 |
0.48 |
|
| 2012 |
Krishnamoorthy S, Recchiuti A, Chiang N, Fredman G, Serhan CN. Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs. The American Journal of Pathology. 180: 2018-27. PMID 22449948 DOI: 10.1016/J.Ajpath.2012.01.028 |
0.369 |
|
| 2011 |
Fredman G, Oh SF, Ayilavarapu S, Hasturk H, Serhan CN, Van Dyke TE. Impaired phagocytosis in localized aggressive periodontitis: rescue by Resolvin E1. Plos One. 6: e24422. PMID 21935407 DOI: 10.1371/Journal.Pone.0024422 |
0.59 |
|
| 2011 |
Serhan CN, Fredman G, Yang R, Karamnov S, Belayev LS, Bazan NG, Zhu M, Winkler JW, Petasis NA. Novel proresolving aspirin-triggered DHA pathway. Chemistry & Biology. 18: 976-87. PMID 21867913 DOI: 10.1016/J.Chembiol.2011.06.008 |
0.361 |
|
| 2011 |
Yang R, Fredman G, Krishnamoorthy S, Agrawal N, Irimia D, Piomelli D, Serhan CN. Decoding functional metabolomics with docosahexaenoyl ethanolamide (DHEA) identifies novel bioactive signals. The Journal of Biological Chemistry. 286: 31532-41. PMID 21757729 DOI: 10.1074/Jbc.M111.237990 |
0.408 |
|
| 2011 |
Fredman G, Serhan CN. Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution. The Biochemical Journal. 437: 185-97. PMID 21711247 DOI: 10.1042/Bj20110327 |
0.483 |
|
| 2011 |
Fredman G, Serhan CN. Specialized pro-resolving mediators: wiring the circuitry of effector immune and tissue homeostasis Endodontic Topics. 24: 39-58. DOI: 10.1111/Etp.12010 |
0.468 |
|
| 2010 |
Fredman G, Van Dyke TE, Serhan CN. Resolvin E1 regulates adenosine diphosphate activation of human platelets. Arteriosclerosis, Thrombosis, and Vascular Biology. 30: 2005-13. PMID 20702811 DOI: 10.1161/Atvbaha.110.209908 |
0.508 |
|
| 2010 |
Ayilavarapu S, Kantarci A, Fredman G, Turkoglu O, Omori K, Liu H, Iwata T, Yagi M, Hasturk H, Van Dyke TE. Diabetes-induced oxidative stress is mediated by Ca2+-independent phospholipase A2 in neutrophils. Journal of Immunology (Baltimore, Md. : 1950). 184: 1507-15. PMID 20053941 DOI: 10.4049/jimmunol.0901219 |
0.486 |
|
| 2008 |
Dona M, Fredman G, Schwab JM, Chiang N, Arita M, Goodarzi A, Cheng G, von Andrian UH, Serhan CN. Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets. Blood. 112: 848-55. PMID 18480426 DOI: 10.1182/Blood-2007-11-122598 |
0.424 |
|
| 2008 |
Chiang N, Schwab JM, Fredman G, Kasuga K, Gelman S, Serhan CN. Anesthetics impact the resolution of inflammation. Plos One. 3: e1879. PMID 18382663 DOI: 10.1371/Journal.Pone.0001879 |
0.445 |
|
| 2006 |
Duffield JS, Hong S, Vaidya VS, Lu Y, Fredman G, Serhan CN, Bonventre JV. Resolvin D series and protectin D1 mitigate acute kidney injury. Journal of Immunology (Baltimore, Md. : 1950). 177: 5902-11. PMID 17056514 DOI: 10.4049/Jimmunol.177.9.5902 |
0.333 |
|
| 2006 |
Ariel A, Fredman G, Sun YP, Kantarci A, Van Dyke TE, Luster AD, Serhan CN. Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression. Nature Immunology. 7: 1209-16. PMID 17013391 DOI: 10.1038/Ni1392 |
0.57 |
|
| 2006 |
Serhan CN, Ariel A, Fredman G, Sun Y, Kantarci A, Dyke TEV, Luster AD. Removal of CCR5 ligands and induction of pro-resolving lipid mediators by apoptotic neutrophils during resolution Nature Protocols. DOI: 10.1038/Nprot.2006.295 |
0.354 |
|
| 2005 |
Ariel A, Li PL, Wang W, Tang WX, Fredman G, Hong S, Gotlinger KH, Serhan CN. The docosatriene protectin D1 is produced by TH2 skewing and promotes human T cell apoptosis via lipid raft clustering. The Journal of Biological Chemistry. 280: 43079-86. PMID 16216871 DOI: 10.1074/Jbc.M509796200 |
0.373 |
|
| Show low-probability matches. |